CanniMed $CMED Receives License from Health Canada to Produce Medical Cannabis Capsules

(TSX: CMED) CanniMed Therapeutics Inc. has initiated production of CanniMed® Capsules, following the receipt of the Production License granted by Health Canada. Subject to Health Canada’s issuance of the required license to sell, CanniMed anticipates the Capsules will be available for patient order … [Read more...]

Isodiol $ISOL to Implement Blockchain Technology for Payment Processing

(CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) Isodiol International Inc., a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, has announced that it is in the final stages of advanced due diligence for implementing Blockchain technology for … [Read more...]

Supreme $FIRE Announces $30MM Bought Deal Private Placement of Convertible Debenture Units

(TSX.V:FIRE) Supreme Pharmaceuticals Inc. announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement … [Read more...]

(TSX.V:NSP) (OTC:NSPDF) (FRANKFURT:50N) Naturally Splendid Enterprises Ltd. is very pleased to announce it has received approval from the Japanese regulatory bodies for two of its CBD capsule products; full spectrum hemp oil NATERA CBD caps and NATERA CBD Ultra Caps. NSE's Natera(R) CBD products … [Read more...]

Aurora $ACB Announces $6M Complementary Private Placement

(TSX: ACB) (OTCQX: ACBFF) (Frankfurt:  21P; WKN: A1C4WM) Aurora Cannabis Inc. announced that further to the Company's previously announced $60 million bought deal financing, as announced and upsized on October 10, 2017, the Company has agreed to a one-time special accommodation for the benefit of … [Read more...]

InMed $IN Names Mauro Maccarrone to Advisory Board

(CSE: IN; OTCQB: IMLFF) InMed Pharmaceuticals Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Mauro Maccarrone is Professor … [Read more...]

Beleave $BE Signs $10mm Financing Deal With Cannabis Wheaton

(CSE: BE) (CSE: BE.CN) (CNSX: BE) (OTCQX: BLEVF) Beleave Inc. and Cannabis Wheaton Income Corp. are pleased to announce that they, along with Beleave's wholly-owned operating subsidiary Beleave Kannabis Corp., have entered a definitive agreement whereby Cannabis Wheaton will provide Beleave with up … [Read more...]